Varian Grows Cancer Portfolio With Endocare & Alicon Acquisitions

Varian is expanding its cancer care solutions portfolio with two new acquisitions in the interventional oncology space. The medtech giant said it will pay $185m to buy Endocare Systems, based in Austin, Texas; and Alicon, based in Hangzhou, China.

Merging Business Network-Business leaders in global agreement

More from Oncology

More from Device Area